Litcius/Paper detail

Early favipiravir treatment was associated with early defervescence in non-severe COVID-19 patients

Satoshi Fujii, Yuta Ibe, Tomoyuki Ishigo, Hirotoshi Inamura, Yusuke Kunimoto, Yoshihiro Fujiya, Koji Kuronuma, Hiromasa Nakata, Masahide Fukudo, Satoshi Takahashi

2021Journal of Infection and Chemotherapy26 citationsDOIOpen Access PDF

Topics & Concepts

FavipiravirCoronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MedicineVirologyInternal medicineOutbreakInfectious disease (medical specialty)DiseaseCOVID-19 Clinical Research StudiesRespiratory viral infections researchSARS-CoV-2 and COVID-19 Research
Early favipiravir treatment was associated with early defervescence in non-severe COVID-19 patients | Litcius